首页> 外国专利> DERIVATIVES OF N-(HETEROARYL)-1-HETEROARYL-1H-INDOL-2-CARBOXAMIDS, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

DERIVATIVES OF N-(HETEROARYL)-1-HETEROARYL-1H-INDOL-2-CARBOXAMIDS, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

机译:N-(杂芳基)-1-杂芳基-1H-吲哚-2-甲酰胺的衍生物,其制备和治疗用途

摘要

N-(Benzo-heterocyclyl)-1-heteroaryl-1H-indole-2-carboxamide derivatives (I) are new. Indole derivatives of formula (I) and their acid addition salts, hydrates and solvates are new. X 1-X 4H, halo, alkyl, cycloalkyl, cycloalkyl-(1-3C) alkyl, fluoroalkyl, alkoxy, fluoroalkoxy, CN, CONR 1R 2, NO 2, NR 1R 2, alkylthio, alkylsulfinyl, alkylsulfonyl, SO 2NR 1R 2, NR 3COR 4, NR 3SO 2R 5 or aryl (optionally substituted (os) by one or more of alkyl, cycloalkyl, cycloalkyl-(1-3C) alkyl, fluoroalkyl, alkoxy, fluoroalkoxy, CN or NO 2); W' : benzo-fused 5-7 membered heterocycle, (i) containing 1-3 of S, O and/or N as heteroatom(s), (ii) bonded to the N of (I) via the benzo ring, (iii) os on C of the heterocyclic ring by one or more of alkyl, cycloalkyl, cycloalkyl-(1-3C) alkyl, fluoroalkyl, alkoxy, cycloalkoxy, cycloalkyl-(1-3C) alkoxy, aryl, arylalkyl, = O or thio and (iv) os on N by R 6 if the N is adjacent to = O or in other cases by R 7; Y' : heteroaryl (os by one or more of halo, alkyl, cycloalkyl, cycloalkyl-(1-3C) alkyl, fluoroalkyl, OH, alkoxy, fluoroalkoxy, CN, CONR 1R 2, NO 2, NR 1R 2, alkylthio, SH, alkylsulfinyl, alkylsulfonyl, cycloalkylsulfinyl, cycloalkylsulfonyl, SO 2NR 1R 2, NR 3COR 4, NR 3SO 2R 5, aryl or arylalkyl (where aryl moieties are os as in X 1-X 4); R 1, R 2H, alkyl, cycloalkyl, cycloalkyl-(1-3C) alkyl, arylalkyl or aryl; or NR 1R 2azetidino, pyrrolidone, piperidino, azepino, morpholino, thiomorpholino, piperazino or homopiperazino (all os by alkyl, cycloalkyl, cycloalkyl-(1-3C) alkyl, arylalkyl or aryl); R 3, R 4H, alkyl, arylalkyl or aryl; R 5alkyl, arylalkyl or aryl; R 6H, alkyl, cycloalkyl, cycloalkyl-(1-3C) alkyl, fluoroalkyl, arylalkyl, alkylcarbonyl, cycloalkyl-(1-3C) alkylcarbonyl, fluoroalkylcarbonyl, cycloalkylcarbonyl, arylcarbonyl, arylalkylcarbonyl, alkylsulfonyl, fluoroalkylsulfonyl, cycloalkylsulfonyl, cycloalkyl-(1-3C) alkylsulfonyl, arylsulfonyl or aryl; ring S and N atoms in W' and Y' are optionally in oxidized form; unless specified otherwise alkyl moieties have 1-6C and cycloalkyl moieties 3-7C. An independent claim is included for the preparation of (I) [Image] ACTIVITY : Analgesic; Antiinflammatory; Urolopathic; Gynecological; Antipsoriatic; Antipruritic; Dermatological; Ophthalmological; Virucide; Neuroprotective; Antidepressant; Antiulcer; Hepatotropic; Antiasthmatic; Antitussive. MECHANISM OF ACTION : TRPV1 receptor antagonist. In a TRPV1 receptor antagonist assay based on inhibtion of the current induced in rat dorsal root ganglions, N-(1,2-dimethyl-1H-benzimidazol-5-yl)-5-fluoro-1-(4,6-dimethyl-pyridin-2-yl)-1H-indole-2-carboxamide (Ia) gave 70% inhibition at a concentration of 10 nM.
机译:N-(苯-杂环基)-1-杂芳基-1H-吲哚-2-羧酰胺衍生物(I)是新的。式(I)的吲哚衍生物及其酸加成盐,水合物和溶剂化物是新的。 X 1-X 4H,卤素,烷基,环烷基,环烷基-(1-3C)烷基,氟代烷基,烷氧基,氟代烷氧基,CN,CONR 1R 2,NO 2,NR 1R 2,烷硫基,烷基亚磺酰基,烷基磺酰基,SO 2NR 1R 2 ,NR 3COR 4,NR 3SO 2R 5或芳基(任选被烷基,环烷基,环烷基-(1-3C)烷基,氟代烷基,烷氧基,氟代烷氧基,CN或NO 2中的一种或多种取代(os)); W':苯并稠合的5-7元杂环,(i)含有1-3个S,O和/或N作为杂原子,(ii)通过苯并环键合至(I)的N,( iii)在杂环的C上通过烷基,环烷基,环烷基-(1-3C)烷基,氟代烷基,烷氧基,环烷氧基,环烷基-(1-3C)烷氧基,芳基,芳基烷基中的一个或多个,= O或硫代的os (iv)如果N与= O相邻,则通过R 6在N上进行os运算,或者在其他情况下通过R 7 Y':杂芳基(由卤素,烷基,环烷基,环烷基-(1-3C)烷基,氟代烷基,OH,烷氧基,氟代烷氧基中的一个或多个制成的os,CN,CONR 1R 2,NO 2,NR 1R 2,烷硫基,SH ,烷基亚磺酰基,烷基磺酰基,环烷基亚磺酰基,环烷基磺酰基,SO 2NR 1R 2,NR 3COR 4,NR 3SO 2R 5,芳基或芳基烷基(其中芳基部分如在X 1-X 4中为os); R 1,R 2H,烷基,环烷基,环烷基-(1-3C)烷基,芳基烷基或芳基;或NR 1R 2氮杂环丁烷基,吡咯烷酮,哌啶子基,氮杂环庚烷,吗啉代,硫代吗啉代,哌嗪子基或高哌嗪子基(所有os均为烷基,环烷基,环烷基-(1-3C)烷基,芳基烷基R 3,R 4H,烷基,芳基烷基或芳基; R 5烷基,芳基烷基或芳基; R 6H,烷基,环烷基,环烷基-(1-3C)烷基,氟代烷基,芳基烷基,烷基羰基,环烷基-(1- 3C)烷基羰基,氟烷基羰基,环烷基羰基,芳基羰基,芳基烷基羰基,烷基磺酰基,氟烷基磺酰基,环烷基磺酰基,环烷基-(1-3C)烷基磺酰基,芳基磺酰基或芳基; W'中的环S和N原子和Y′任选地为氧化形式;除非另有说明,否则烷基部分具有1-6C且环烷基部分具有3-7C。制备(I)包括一个独立的权利要求。消炎(药;尿毒症;妇科对牛皮癣;止痒;皮肤;眼科杀病毒剂;具有神经保护作用;抗抑郁药抗溃疡;肝抗哮喘镇咳药。作用机理:TRPV1受体拮抗剂。在基于抑制大鼠背根神经节诱导电流的TRPV1受体拮抗剂测定中,N-(1,2-二甲基-1H-苯并咪唑-5-基)-5-氟-1-(4,6-二甲基-吡啶-2-基)-1H-吲哚-2-羧酰胺(Ia)在10 nM的浓度下产生70%的抑制作用。

著录项

  • 公开/公告号EP2125787B1

    专利类型

  • 公开/公告日2017-03-01

    原文格式PDF

  • 申请/专利权人 SANOFI;

    申请/专利号EP20080761774

  • 申请日2008-01-17

  • 分类号C07D401/14;A61K31/4439;A61P25;A61P17;A61P13;A61P11;

  • 国家 EP

  • 入库时间 2022-08-21 14:06:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号